APOE and Alzheimer disease: This study investigated whether performance assessed over episodic memory, executive and attentional domains in healthy late-middle-aged individuals is associated with a combination of risk/protective factors (crystallized intelligence, sympathetic functioning and lipid metabolism, sex, age, and APOE status) as well as with levels of AD-related brain biomarkers (Aβ and THK5351 uptake).